We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fast, Accurate Assay Differentiates Between Campylobacter Species

By Biotechdaily staff writers
Posted on 12 Feb 2007
A real-time polymerase chain reaction (PCR) assay differentiates between three species of Campylobacter.

Most current screening procedures for Campylobacter are culture-based, take at least three days for a result, and do not differentiate between species without additional investigational work. More...
The new Bax assay differentiates between the pathogenic species C jejuni, C coli, and C lari, and quantifies them. Results for highly contaminated samples (direct protocol) are available the same day, and take up to 48 hours for samples requiring enrichment

Oxoid Limited (Basingstoke, UK), marketing partner for the DuPont Qualicon Bax System in Europe, Australia, and Canada, launched the new Bax real-time PCR assay for Campylobacter. PCR is a method used for amplifying and detecting specific DNA in a sample. The Bax real-time Campylobacter assay, the first in a series of new real-time assays from DuPont Qualicon, uses PCR and probe-based chemistry to detect, quantify, and differentiate between these three species of Campylobacter in the same sample.

Target-specific probes (linked with different fluorescent markers) are displaced and cleaved from their target DNA during the amplification process, resulting in an increase in fluorescence. This fluorescence is measured at the end of each amplification cycle in real time. The system is simple and easy to use. Lysis is straight-forward and requires no additional equipment. All reagents required for PCR are supplied in a single tablet conveniently packaged inside the PCR tubes provided in each kit. Tableted reagents minimize the amount of hands-on time required for processing whilst simultaneously simplifying and standardizing the procedure. Results are interpreted automatically and are ready for reporting. If necessary, icons and graphs make further result interrogation simple and easy to visualize.

Campylobacter infection is a worldwide public health concern and is the leading cause of enteric illness in many countries. Campylobacter species differ from other food pathogens in that they do not multiply within the food. However, as few as 500 cells are sufficient to cause infection. The organism is endemic in many poultry populations and whilst normally responsible for self-limiting enteritis, infection in man can lead to severe complications such as arthritis and Guillain-Barré syndrome, an acute paralytic disease of the nervous system. Although C jejuni is responsible for approximately 90% of infections, C coli and C lari have also been implicated.




Related Links:
Oxoid

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.